Cefazolin as second line treatment for invasive Methicillin-Susceptible Staphylococcus aureus infection in a UK cohort of patients.

Young BC., Dunsmure L., Downs L., Kildonaviciute K., Jones N.

DOI

10.1016/j.jinf.2021.01.024

Type

Journal article

Journal

The Journal of infection

Publication Date

03/02/2021

Addresses

Microbiology and Infectious Diseases Department, Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Oxford OX3 9DU, United Kingdom; Nuffield Department of Medicine, Experimental Medicine Division, University of Oxford, John Radcliffe Hospital, Oxford OX3 9DU, United Kingdom.

Permalink Original publication